National Health Investors (NYSE:NHI) Releases FY20 Earnings Guidance

Share on StockTwits

National Health Investors (NYSE:NHI) issued an update on its FY20 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $5.67-$5.71 for the period, compared to the Thomson Reuters consensus estimate of $5.66. National Health Investors also updated its FY 2020
Pre-Market guidance to 5.31-5.35 EPS.

NYSE:NHI opened at $90.79 on Friday. The company has a debt-to-equity ratio of 0.96, a current ratio of 16.40 and a quick ratio of 14.11. The business has a fifty day simple moving average of $85.11 and a two-hundred day simple moving average of $82.83. National Health Investors has a 1 year low of $73.62 and a 1 year high of $91.00. The company has a market capitalization of $4.02 billion, a P/E ratio of 16.39 and a beta of 0.29.

National Health Investors (NYSE:NHI) last released its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.95 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.41 by ($0.46). National Health Investors had a return on equity of 11.07% and a net margin of 50.44%. The firm had revenue of $82.20 million during the quarter, compared to analysts’ expectations of $79.92 million. During the same period in the prior year, the business earned $1.35 earnings per share. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. As a group, analysts anticipate that National Health Investors will post 5.69 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Tuesday, March 31st will be given a $1.1025 dividend. The ex-dividend date is Monday, March 30th. This is a boost from National Health Investors’s previous quarterly dividend of $1.05. This represents a $4.41 annualized dividend and a dividend yield of 4.86%. National Health Investors’s payout ratio is 76.36%.

Several equities analysts have recently weighed in on NHI shares. BMO Capital Markets upgraded National Health Investors from an underperform rating to a market perform rating and lifted their price target for the company from $74.00 to $82.00 in a research report on Tuesday, January 7th. Mizuho reiterated a buy rating and issued a $95.00 price target on shares of National Health Investors in a research report on Friday, December 20th. Berenberg Bank started coverage on National Health Investors in a research report on Wednesday, February 5th. They issued a buy rating and a $94.00 price target for the company. ValuEngine upgraded National Health Investors from a sell rating to a hold rating in a research report on Friday, October 25th. Finally, Zacks Investment Research cut National Health Investors from a hold rating to a sell rating in a research report on Saturday, November 9th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company. The company currently has an average rating of Hold and an average price target of $90.25.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Story: Cryptocurrencies

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.